Key Takeaways: ADHD affects about 6 million U.S. children, highlighting its significant prevalence and rising diagnosis rates. Clinicians are invited to share insights on adult ADHD assessment, comorbidities, and treatment considerations. Example topics include ADHD’s link with bipolar disorder, anxiety, depression, and cardiovascular risks from long-term medication. Contributions may be featured in a content series…

A new study by researchers at Simon Fraser University is shedding light on how the brain’s wiring in early childhood lays the foundation for attention skills— a key step toward characterizing healthy developmental patterns that could help identify young children at risk for attention-related challenges like ADHD.

New research reveals how impulsive personality traits steer food choices and alter the gut microbiome, underscoring the potential for dietary strategies to support mental and gut health.

Children with precocious puberty had a nearly 50% elevated risk of developing disorders like depression, anxiety, ADHD, and substance disorders.

On a recent weekday evening, Ashly Richards helped her 13-year-old son, Case, with homework. He did math problems and some reading, underscoring how much he’s accomplished at his school for children with autism. Richards has heard Trump administration officials suggest that food dyes and pediatric vaccines cause autism and ADHD. That stance, she said, unfairly…

[Excerpt] Evidence Summary: Adult prescription stimulant misuse has declined significantly in recent years, driven by a decrease in amphetamine mixed salts misuse among young adults. The Monitoring the Future study found that past year misuse of this medication among adults ages 19 to 30 fell from 7.8 percent in 2022 to 3.7 percent in 2023,…

TUESDAY, Aug. 5, 2025 (HealthDay News) — Among U.S. adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and 2023, while nonmedical use decreased, according to a research letter published online July 29 in the Journal of the American Medical Association.

Cingulate announced today that it has received a fiscal year 2025 Prescription Drug User Fee Act (PDUFA) fee waiver from the US Food and Drug Administration (FDA) for its new drug application (NDA) for dexmethylphenidate HCI (CTx-1301) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 years and older.1

HUNTSVILLE, Ala. (WAFF) – The next few weeks mean it’s Back to School for kids all across the Tennessee Valley, and parents are getting them ready to head back to the classroom. For many, part of back-to-school preparation is ensuring they have their child’s prescription medication on hand. For almost three years, parents have struggled…

As school returns, parents and teachers might each be faced with the familiar chorus of “I can’t find my school jumper” and “I left my hat at home”. For parents of older kids, the stakes may be even higher: lost mobile phones or laptops left on the bus. As parents, it can be tempting to…

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in partnership with University College London and Anna Freud, has found that negative school experiences generate twice the emotional burden in autistic and ADHD adolescents compared to their neurotypical classmates, and that this is significantly correlated with depression and anxiety.

Despite what one popular theory might make you believe.